ISIS:
Analysis & Opinions
-
July 30, 2010
Sanofi is priced as though it will never grow again - that's usually a good sign of value.
-
June 22, 2010
Clinical failure is not the end of the story for all biotechs. How do some survive while others disappear?
-
June 27, 2008
Biotech has been sickly for more than a year, but the sector is showing signs of life. Learn which smaller names are ...
